featured
Measurable Residual Disease Affects Allo-HCT in Ph+ Acute Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Measurable Residual Disease Affects Allogeneic Hematopoietic Cell Transplantation in Ph+ ALL During Both CR1 and CR2
Blood Adv 2021 Jan 26;5(2)584-592, S Nishiwaki, Y Akahoshi, S Mizuta, A Shinohara, S Hirabayashi, Y Noguchi, T Fukuda, N Uchida, M Tanaka, M Onizuka, Y Ozawa, S Ota, S Shiratori, Y Onishi, Y Kanda, M Sawa, J Tanaka, Y Atsuta, S KakoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.